Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

NCT00368927 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

NIH

Sponsor class

Conditions

Precancerous Condition
Stage I Non-small Cell Lung Cancer
Tobacco Use Disorder

Interventions

DRUG: sulindac
OTHER: placebo

Sponsor

National Cancer Institute (NCI)